Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meetings to be conducted. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In furtherance to the intimation captioned "US FDA Inspection at Alkem's manufacturing facility located at Indore" dated 07th July, 2022, this is to inform you that US FDA has issued an Establishment Inspection Report (EIR) for the Company's manufacturing facility located at Indore which was inspected from 01st July, 2022 to 07th July, 2022. In response to Form 483 issued by the US FDA containing one observation, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The inspection has now been closed by the US FDA. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting to be conducted. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting to be conducted. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meetings to be conducted. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We enclose herewith the transcript of the 'Q3 FY2023 Earnings Conference Call' which was hosted by the Company on Friday, 10th February, 2023. The said transcript shall also be made available on the website of the Company. Kindly take the same on record
Alkem Laboratories Results Earnings Call for Q3FY23
Conference Call with Alkem Laboratories Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q3FY23 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php. Kindly take the same on records.
Alkem Laboratories Ltd - 539523 - Closure of Trading Window
We refer to our earlier communication dated 23rd December, 2022 regarding closure of trading window (for the purpose of financial results for the quarter ended 31st December, 2022) starting from 30th December, 2022 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and nine months ended 31st December, 2022 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter and nine months ended 31st December, 2022 having been communicated to the Stock Exchanges, today i.e. 10th February, 2023, the trading window shall open on 13th February, 2023.